去势大鼠骨关节炎软骨组织中蛋白激酶B变化的实验研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:观察实验性骨关节炎发生发展过程中软骨组织Akt的表达及卵巢去势后Akt的表达,探讨大鼠骨关节炎进程中雌激素缺乏对软骨组织中Akt的影响,研究其变化规律,为进一步研究雌激素在OA发展过程中所起作用提供依据。
     方法:2-3月龄SPF级健康SD雌性大鼠72只,分为三组:16只作为正常对照组,56只为OA建模组,每只鼠行双侧膝关节前交叉韧带切断和部分内侧半月板切除构建OA动物模型。术后第6周处死8只OA建模大鼠及4只正常对照大鼠,取材检测OA建模情况;余下48只建模大鼠再随机分为两组:OA组24只,OA+OVX组24只(行双侧卵巢切除);于第9周、12周、16周再分别处死正常对照组4只, OA组和OA+OVX组各8只大鼠,取材双侧膝关节。HE染色、番红O染色行软骨组织病理学观察;S-P免疫组化法和Western-blotting法分析软骨组织中Akt及P-Akt的表达,SPSS统计软件进行统计学处理。
     结果:构建OA动物模型及绝经期动物模型成功。OA造模术后第6周关节软骨出现明确的骨关节炎病理改变,且病变逐渐加重。在各随访时间点上, OA组与OA +OVX组两组组间Mankin’s评分比较未发现两者间有差异(P >0.05),提示组织学上看不出卵巢去势后雌激素缺乏状态下骨关节炎有明显加重趋势。但在各随访时间点上,OA组与OA+OVX组Akt的表达有差异,后者较前者低,差异有显著性(P<0.05)。OA组与OA+OVX组Akt、P-Akt的表达水平均呈现先升高后下降的变化过程,术后第6周到第12周,OA组软骨组织出现轻到中度损伤,此时Akt、P-Akt的表达水平呈现逐渐升高,术后第16周时,关节软骨组织处于中到重度损伤,此时Akt、P-Akt表达水平下降,时间轴上Akt表达量差异有显著性(P<0.01)。
     结论:1.通过切断前交叉韧带和切除部分内侧半月板的方法构建早期OA动物模型是成功、可行的。2.在本实验期内,组织学上看不出卵巢去势后骨性关节炎有明显加重趋势。3. Akt、P-Akt的表达水平随OA的发展呈现先升高后下降趋势。4.卵巢切除后,Akt表达水平下降,提示雌激素缺乏可影响软骨组织中Akt的表达。
Objective To research regularity for change of protein Kinase B in the articular cartilage of osteoarthritis(OA) process in OA and OA-ovariectomy rat models.
     Methods 72 female Sprague-Dawley rats were used in this study. 16 rats were the control group, 56 rats were performed operation at both knees to induce OA by anterior cruciate ligament transection (ACLT) in combination with resection of part medial menisci (part-MMx). At 6 weeks, we detected the OA model by killing 8 rats(ACLT+ part-MMx), compared with 4 control rats. The other 48 rats were divided into two group: OA group(24 rats) and OVX + OA group(24rats). The OVX + OA group was performed by both side ovariectomy. The articular cartilage in medial femoral condyle and femoral trochlea of control rats(4 ), OA rats(8 ) and OVX + OA rats (8) were acquired at 9, 12, and 16 weeks postoperation, respectively. We observed the morphological change of the articular cartilage in OA rat model by histological technique, including haemotoxylin(H.E.) and safranin O, and detected the expression of Akt and P-Akt by immunohistochemical technique and Western-Blotting from 6 to 16-week post-operation. All data were analyzed in SPSS statistical program.
     Results We established the OA and OA-OVX rat model, in which the morphological change of articular cartilage is accordance with the histopathological structure of OA. However, it is no significant morphological change in the articular cartilage following the decrease of estrogen by OVX in OA rat model (P>0.05). Furthermore, we observed that the expression of Akt and P-Akt in articular cartilage in OA-OVX model is significantly lower than that in OA model (P<0.05).But the expression of Akt and P-Akt in articular cartilage gradually increased in a time-dependent manner from 6 to 12-week post-operation (P<0.01), and then the expression of Akt and P-Akt decreased rapidly in 16-week post-operation (P<0.05),whether in OA or in OA-OVX rat model.
     Conclusion It is adoptable to establish the OA rat model by ACLT and part-MMX. And it is no more significant effect on the morphological structure of articular cartilage after OVX in OA rat model. It is suggested that the decrease of estrogen by OVX may be associated with the decrease of the expression of Akt and P-Akt.
引文
[1]唐福林,应重视骨与关节病的研究.中华全科医师杂志,2003.2(6).337-338.
    [2] Herndon, James H. Osteoarthritis in women after menopause [J]. Menopause, 2004; 11 (5) : 499-501.
    [3] H-L Ma,T.J Blanchet,D. Peluso,B Hopkins,et al,Osteoarthritis severity is sex dependent in a surgical mouse model Osteoarthritis and Cartilage, 2007;15( 6), 695-700.
    [4] Nevitt MC, Felson DT, Williams EN, et al. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women[J]. Arthritis Rheum, 2001; 46 (44) : 811-818.
    [5] Erb A, Brenner H, Gunther KP, Sturmer T: Hormone replacement therapy and patterns of osteoarthritis: baseline data from the Ulm Osteoarthritis Study. Ann Rheum Dis 2000, 59: 105-109.
    [6] Ushiyama T, Ueyama H,et al. Expression of genes for estrogen receptorsαandβin human articular chondrocytes. Osteoarthritis and Cartilage (1999) 7, 560–566.
    [7] Hanna FS, Wluka AE, Bell RJ, Davis SR, Cicuttini FM.Osteoarthritis and the postmenopausal woman: epidemiological, magnetic resonance imaging, and radiological findings. Semin Arthritis Rheum2004;34:631-6.
    [8] Gokhale JA, Frenkel SR, Dicesare PE. Estrogen and osteoarthritis. Am J Orthop 2004;33:71-80
    [9] Kurz B, Lemke AK, Fay J, Pufe T, Grodzinsky AJ, Schunke M. Pathome-chanisms of cartilage destruction by mechanical injury. Ann Anat 2005;187:473-85.
    [10] Monfort J, Garcia-Giralt N, Lopez-Armada MJ, Monllau JC, Bonilla A, Benito P, et al. Decreased metalloproteinase production as a response to mechanical pressure in human cartilage: a mechanism for homeostasis regulation. Arthritis Res Ther 2006;8:R149.
    [11] Min JL, Meulenbelt I, Kloppenburg M, Van Duijn CM, Slagboom PE. Mutation analysis of candidate within the 2q33.3 linkage area for familialearly-onset generalized osteoarthritis.Eur JHumGenet 2007;15:791-9.
    [12] Martel-Pelletier J, Tardif G, Fernandes JC, Pelletier JP.Metalloproteases and their modulation as treatment in osteoarthritis. In: Tsokos GC, Ed. Molecular Rheumatology. Totowa, New Jersey: Humana Press Inc 2000;499–514.
    [13] Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 1997;100:93–106.
    [14] Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, et al. Purification and loning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999;284:1664–6.
    [15] Heraud F, Heraud A, Harmand MF. Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 2000;59:959–65.
    [16] Kouri JB, Aguilera JM, Reyes J, Lozoya KA, Gonzalez S. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormalcalcilcation of subchondral bone. J Rheumatol 2000;27:1005–19.
    [17]裴明,曲绵城,于长隆,等,凋亡在骨关节病发病机制中的作用.[J].中华骨科杂志,1999,11 (3):167~169.
    [18] Blanco FJ,Guitian R,Vazquez Martul E.et al.Osteoarthritis chonodrocytes did by apoptosis :A possible pathway for osteoarthritis pathology.[J ].Arthritis Rheum ,1998 ,41 (2) :284~289.
    [19] Kim HA, Blanco FJ. Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets, 2007, 8(2):333-345.
    [20] Sanshiro Hashimoto , Robert J Ochs , Martin Lots , et al .Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis[J ] Arthritis Rheum ,1998 ,41(9) :1632~1637.
    [21] Pelletier J P ,Jovanovic DV ,Lascau 2Coman V. Selective inhibition of inducible nit ric oxide synthase reduces progression of esperimental osteoarthritis in vivo :possible link with the reduction in chondrocyte apoptossis and caspase 3 level [J ] Arthritis Rhcum ,2000 ,43(6) :1290~1291.
    [22] Brazil DP, Hemmings BA. Ten years of protein kinase B signalling:a hard Akt to follow. TRENDS in Biochemical Sciences. 2001;26:657–664.
    [23] Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Current Opinion in Cell Biology 1998;10:262-267.
    [24] Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway. Current Opinion in eurobiology 2001;11:297-305.
    [25] Oh CD, Chun JS. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem., 2003, 278(38):36563-36571.
    [26] Qureshi HY, Ahmad R, Sylvester J, et al Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-βin human chondrocytes. Cell Signal, 2007, 19(8):1643-1651
    [27] Shakibaei M, John T, Schulze-Tanzil G, et al Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol, 2007, 73(9):1434-1445.
    [28] Ulici V, Hoenselaar KD, Gillespie JR, et al The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation. BMC Dev Biol, 2008, 8:40-55.
    [29] Marijnissen AC, van Roermund PM,VerzijlN, et al . Steady progression of osteoarthritic features in the canine groove model[ J ]. Osteoarthritis Cartilage, 2002, 10 (4) : 282- 289.
    [30]欧云生,安洪.鼠骨关节炎动物模型建立的现状[ J ].中国比较医学杂志, 2004, 14 (1) : 41- 44.
    [31] Pernille H?egh-Andersen,LászlóB Tankó,Thomas L Andersen,et.al Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application[J]. Arthritis Res Ther. 2004; 6(2): 169–180.
    [32] YH Sniekers, H Weinans, SM Bierma-Zeinstra et.al, Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment– a systematicapproach. [J]. Osteoarthritis and Cartilage, 2008;16(5) 533-541.
    [33] H Brommer,van Weeren PR,Brama PA,New approach for quantitative assessment of articular cartilage degeneration in horses with osteoarthritis. Am J Vet Res,2003.64(1).83-87.
    [34] HJ Mankin,Dorfman H,Lippiello L,et al.Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips:ⅡCorrelation of morphology with biochemical and metabolic data.J Bone Joint Surg Am,1971.53A.523-537.
    [35] H Lorenz,Wenz W,Ivancic M,et al.Early and stable upregulation of collagen type II,collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading.Arthritis Research&Therapy,2005. 7(1).156-165.
    [36] DL Batiste,Kirkley A,Laverty S,et al.Ex vivo characterization of articular cartilage and bone lesions in a rabbit ACL transection model of osteoarthritis using MRI and micro-CT.Osteoarthritis Cartilage,2004.12(12).986-996.
    [37] AA Valburg,Roermund PM,Marijnissen AC,et al.Joint distraction in treatment of osteoarthritis(II):effects on cartilage in a canine model. Osteoarthritis Cartilage,2000.8(1).1-8.
    [38] Bendele A. Animal models of osteoarthritis. [J] Musculoskelet NeuronalInteract 2001;1:363–76.
    [39] Bluteau G.Gouttenoire J.Conrozier T Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section . [J].2002,39(14):247
    [40]陈蔚东;蒋青;陈东阳等,p38蛋白激酶抑制剂对大鼠骨关节炎的软骨保护作用[J],山东医药,2007,47(10):21-22.
    [41]杨瑞甫,胡蕴玉,吴银松等,兔骨关节炎两种动物模型的比较[J],中国矫形外科杂志,2006,14(19):1497-1499
    [42]葛广勇,赵建宁,刘刚,膝骨性关节炎模型的分期特征[J],中国临床康复,2006.10(4):47-49.
    [43] Brazil DP, Hemmings BA. Ten years of protein kinase B signalling:a hard Akt to follow. TRENDS in Biochemical Sciences. 2001;26:657–664.
    [44] Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer. nature reviews cancer 2002;2:489-501.
    [45]张兵,吴乔.蛋白激酶B的特性及其生物学功能.细胞生物学杂志, 2002, 24(4):209-212.
    [46] Malemud C J . Protein kinases in chondrocyte signaling and osteoarthritis [ J ]. Clin Orthop Relat Res, 2004, ( 427 Supp l) :145 - 151.
    [47] Mistry D, Oue Y, Chambers M G, et al .Chondrocyte death during murine osteoarthritis[ J ]. Osteoarthritis Cartilage, 2004,12 (2) : 131 - 141.
    [48] Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T, Kitajima I. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. [J].J Bone Miner Metab. 2005;23(6):411-9.
    [49] Pelletier J P,Lascau-Coman V,Jovanovic D, et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors [J].Rheumatol. 1999 Sep;26(9):2002-14.
    [50] Laemmli UK, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. [J].Nature 1970;227:680-685.
    [51] Turner AS, Athanasiou KA, Zhu CF, Alvis MR, Bryant HU. Biochemical effects of estrogen on articular cartilage in ovariectomized sheep .[J ].Osteoarthritis Cartilage 1997;5:63-9.
    [52] Dai G, Wang S, Li J, Liu C, Liu Q. The validity of osteoarthritis model induced by bilateral ovariectomy in guinea pig. [J ] Huazhong Univ Sci Technolog Med Sci 2006;26:716-9.
    [53] Ham KD, Loeser RF, Lindgren BR, Carlson CS. Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. [J ].Arthritis Rheum 2002;46:1956-64.
    [54] Hashem G, Zhang Q, Hayami T, Chen J, Wang W, Kapila S. Relaxin and beta-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss. [J ].Arthritis Res Ther 2006;8:R98.
    [55] Chambers MG, Cox L, Chong L, Suri N, Cover P, Bayliss MT, et al. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. [J ].Arthritis Rheum 2001;44:1455-65.
    [56] Stabile V , Russo M , Chieffi P . 17beta-estradiol induces Akt-1 through estrogen receptor-beta in the frog (Rana esculenta) male germ cells. [J ].Reproduction. 2006 Sep;132(3):477-84.
    [57] Zhu L, Pollard JW. Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling. [J ].Proc Natl Acad Sci U S A. 2007, 104:15847-15851.
    [58] Young-Rae Lee, Jinny Park , Hong-Nu Yu ,et al. Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-a, but not estrogen receptor-β,and stimulates cell growth in breast cancer cells. [J].Biochemical and Biophysical Research Communications, 2005,336 :1221–1226.
    [1] Frances M.K. Williams,tim D spector. Osteoarthritis. Medicine, Volume 34, Issue 9, September 2006, Pages 364-368.
    [2] Herndon, James H. Osteoarthritis in women after menopause [J]. Menopause, 2004; 11 (5) : 499-501.
    [3] Nevitt MC, Felson DT, Williams EN, et al. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women[J]. Arthritis Rheum, 2001; 46 (44) : 811-8.
    [4] Christgau S, Cloos PA. Sex hormones in the regulation of bone and cartilage metabolism: an old paradigm and a new challenge: Minerva Ginecol, 2005 57(6):611-617.
    [5] Christgau S, Tanko LB; Cloos PA, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).Menopause, 2004,11(5):508-518.
    [6] Ushiyama T, Ueyama H,et al. Expression of genes for estrogen receptorsαandβin human articular chondrocytes. Osteoarthritis and Cartilage (1999) 7, 560–566.
    [7] Claassen H, Hassenpflug J, Schunke M, et al1 I mmunohist ochemical detection of estr ogen receptor alpha in articular chondrocytes fr om cows,pigs and humans : in situ and in vitro results〔J〕,Annals Anatomy, 2001;183 (3) : 223-7.
    [8] Richmond RS, Carls on CS, Register TC, et al,Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin2like gr owth factor binding protein 2〔J〕,Arthritis Rheum, 2000; 43 (9) : 2081- 90.
    [9] Ben-Hur H,Mor G,Blick stein I , et al ,Loncalization of estrogen receptors in long bones and vertebrae of human fetuse〔sJ〕.Calcif Tissue Int,1993; 53 (2) : 91-6.
    [10] Bergink AP, Van-Meurs JB, Loughlin J, et al,Estrogen receptor alphagene hap lotype is associated with radiographic osteoarthritis of the knee in elderly men and women〔J〕,Arthritis Rheum, 2003; 48 ( 7 ) : 1913-22.
    [11] Ha KY, Chang Cheong HK, KiW, et al,Exp ression of Estrogen Receptorof the Facet Joints in Degenerative Spondylolisthesi〔s J〕,Sp ine, 2005 ;30 (5) : 562- 6.
    [12]于世宾,王美青,赵伟.雌激素受体a在大鼠颞下颌关节中表达的初步研究.实用口腔医学杂志,2006,22(2):207-210.
    [13]白玉兴,罗颂椒.下颌髁突软骨雌激素受体的测定.北京口腔医学,,2000:8(幻-163-165.
    [14] Dai Guofeng, Li Jianmin, Liu Xinyu, et al. The Relationship of the Expression of Estrogen Receptor in Cartilage Cell and Osteoarthritis Induced by Bilateral Ovariectomy in Guinea Pig.Journal of Zuazhong University ofScience and Technology:Medical Edition,2005,25(6):683-686.
    [15]陈崇伟,卫小春,关节软骨胶原变化与骨关节炎的关系〔J〕,中华风湿病学杂志, 2003; 7 (1) : 43-51.
    [16]庞炜,王治伦,周扬,等,雌激素缺乏对软骨代谢影响的实验研究〔J〕,中国地方病防治杂志, 2005 ; 20 ( 3) : 146-7.
    [17] Yuan GH,Masuko-Hongo K, Kat o T, et.al,I mmunologic intervention in the pathogenesis of osteoarthritis〔J〕,Arthritis Rheum, 2003; 48 ( 3 ) :602-11.
    [18]沈权,张文辉,吴春,等,血清抗Ⅱ型胶原抗体与骨关节炎关系的研究〔J〕,浙江创伤外科, 2005; 10 (5) : 331- 2.
    [19] Oestergaard S, Sondergaard BC, Hoegh-Andersen P, et al. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum, 2006, 54(8):2441-2451.
    [20] Mouritzen U, Christgau S,Lehmann HJ, et .al,Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products : influence of age, sex, menopause, hormone replacement therapy, and body mass index〔J〕,Ann Rheum Dis, 2003; 62 (4) : 332-6.
    [21]杨建辉,吕建国,申晓东.雌激素对骨关节炎模型软骨基质蛋白多糖变化的影响.西安交通大学学报:医学版,2004,25(1):48~50.
    [22]万荣,杨庆铭,邓廉夫,等.雌激素对软骨细胞胶原表型表达的影响.中国运动医学杂志,2005,24(2):187190.
    [23]万荣,杨庆铭·雌激素对软骨细胞蛋白多糖表型表达的影响·中国运动医学杂志,2002,21(5):475478.
    [24] Parker D, Hwa SY, Sambr -ook P, et al,Estrogen replacement therapy mitigates the loss of joint cartilage proteoglycans and bone mineral density induced by ovariect -omy and osteoarthritis〔J〕,J Rheumatol, 2003; 6(2) : 116-27.
    [25] Corvol M-T, Carrascosa A, Tsagris L, Blanchard O,Rappaport R. Evidence of a direct in vitro action of sex steroids on rabbit cartilage cells during skeletal growth: in?uence of age and sex. Endocrinology. 1987; 120:1422–9.
    [26] Lee YJ, Lee EB, Kwon YE, et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes. Rheumatol Int (2003) 23: 282–288.
    [27]万荣、杨庆铭等。不同浓度雌激素对软骨细胞金属蛋白酶mRNA表达的影响。Chin J Rheumatol, June 2002,l6 (3):174-177.
    [28] Sadowski T, Steinmeyer J. Effects of non-steroidal anti-inflammatory drugs and dexamethas one on the activity and expression of matrixmetalloproteinase-1,matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes[J]. Osteoarthritis Cartilage, 2001;9 (5): 407-15.
    [29]宋亦军,吴志宏,林守清等。雌、孕激素对兔膝关节滑膜中金属蛋白酶及其组织抑制物和白介素1βmRNA表达的影响[J]。中华医学杂志,2003,83(6) :498-503.
    [30] Chiu KM, Arnaud CD, Ju J, Mayes D, Bacchetti P, Weitz S, Keller ET.Correlation of estradiol parathyroid hormone, IL-6, and soluble IL-6 receptor during the normal menstrual cycle. Bone 2000;26:79–85.
    [31] Tessier C, Prigent-Tessier A, Barkai U, Ferguson-Gottschall S, Srivastava RK, Faliszek J, Gibori G. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17b-estradiol and prolactin. Endocrinology 1999;140:4442–50.
    [32] Ham K D, Oegema TR et al. Effects of long-term estrogen replacement therapy on articular cartilage IGFBP-2, IGFBP-3, collagen and proteoglycan levels in ovariectomized cynomolgus monkeys. OsteoArthritis and Cartilage 2004,12(2):160–168.
    [33] Fernihough JK, Richmond RS, Carlson CS, et al. Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum 1999; 42(10):2103-11.
    [34]万荣、杨庆铭等。雌激素对关节软骨细胞生长因子mRNA表达的影响。Shanghai Med J, 2005,28 (2):104-105.
    [35]万荣,杨庆铭,邓廉夫,等.雌激素对关节软骨细胞生长因子mRNA表达的影响.上海医学,2005,28(2):104106.
    [36]万荣,杨庆铭.不同浓度雌激素对软骨细胞金属蛋白酶mRNA表达的影响.中华风湿病学杂志,2002,6(3):174177.
    [37]肖德明,王晶.雌激素缺乏对兔关节软骨甲状旁腺激素相关肽表达的影响.中国骨肿瘤骨病,2003:2(1):42~44.
    [38] Liu SH, al-Shaikh R, Panossian V, Yang RS, Nelson SD, Soleiman N,et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res 1996;14:526-33.
    [39] Dietrich W, Haitel A, Holzer G, Huber JC, Kolbus A, Tschugguel W. Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig 2006;13:512-7.
    [40] Yao X; Chen H, Ohtake N, et al.Morphological alterations in the growth plate cartilage of ovariectomized mice. Med Mol Morphol, 2006, 39(4):193-197.
    [41] Talwar RM, Wong BS; Svoboda K, et al. Effects of estrogen on chondrocyte proliferation and collagen synthesis in skeletally mature articular cartilage. J Oral Maxillofac Surg, 2006;64(4):600-609.
    [42] Cake MA, Appleyard RC; Read RA, et al. Ovariectomy alters the structural and biomechanical properties of ovine femoro-tibial articular cartilage and increases cartilage iNOS.Osteoarthritis Cartilage, 2005,13(12):1066-1075.
    [43] Hoegh-Andersen P, Tanko LB, Andersen TL, et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther, 2004, 6(2):R1698-1700.
    [44] Wluka AE, Wolfe R, Davis SR, et al. Tibial cartilage volume change in healthy postmenopausal women: a longitudinal study. Ann Rheum Dis, 2004, 63(4):444-449.
    [45]宋亦军,林守清.雌激素与女性骨关节炎.国外医学:妇产科学分册,2005,32(5): 271一273,
    [46] Erb A,Brenner H, Gunther KP, et al,Hormone replacement therapy and patterns of osteoarthritis : baseline data from the Ulm OsteoarthritisStudy{J},Ann Rheum Dis, 2000; 59 (2) : 105-9.
    [47] Sniekers YH et al., Animal models for osteoarthritis: the effect of ovariectomy and estrogen treatment --a systematic approach,Osteoarthritis Cartilage (2008), doi:10.1016/j.joca.2008.01.002.